GWLL — Goldenwell Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $64.35m
- $64.48m
- $0.00m
Annual cashflow statement for Goldenwell Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.117 | -0.985 | -0.117 | -0.132 | -0.296 |
| Non-Cash Items | — | — | 0.002 | 0.008 | 0.008 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.088 | -0.087 | 0.003 | 0 | 0.265 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.205 | -1.07 | -0.113 | -0.123 | -0.023 |
| Financing Cash Flow Items | 0.078 | — | -0.025 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.17 | 0.905 | 0.12 | 0.119 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.035 | -0.168 | 0.007 | -0.004 | -0.023 |